Cubist Systematic Strategies, LLC Bio N Tech Se Call Options Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $136,365 - $169,125	1,500 Added 6.3%	25,300 $2.67 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $307,740 - $388,980	3,000 Added 14.42%	23,800 $2.57 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $1.24 Million - $1.55 Million	10,100 Added 94.39%	20,800 $2.59 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $355,290 - $558,150	-3,000 Reduced 21.9%	10,700 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $765,900 - $1.1 Million	6,000 Added 77.92%	13,700 $1.85 Million
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $949,025 - $1.43 Million	7,700 New	7,700 $1.15 Million

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.